Concepedia

Bonny Gaffney

BG

Statistics

Publications

4

Citations

117

H-Index

4

Active since

2017

Affiliations

CCP Technologies (United States)(Current)

Bonny Gaffney is an author at CCP Technologies (United States) specializing in oncology, cancer immunotherapy, and molecular oncology.

Publications per year

2017–2019

4

Publications

4

CC-115, a dual inhibitor of mTOR kinase and DNA-PK, blocks DNA damage repair pathways and selectively inhibits ATM-deficient cell growth <i>in vitro</i>

Toshiya Tsuji, Lisa M. Sapinoso, Tam Tran et al. · Oncotarget · 2017 · 63 citations · Full text

, , +15

CC-92480 Is a Novel Cereblon E3 Ligase Modulator with Enhanced Tumoricidal and Immunomodulatory Activity Against Sensitive and Resistant Multiple Myeloma Cells

Antonia Lopez‐Girona, Courtney G. Havens, Gang Lu et al. · Blood · 2019 · 21 citations

, , +15

CC-92480, a Novel Cereblon E3 Ligase Modulator, Is Synergistic with Dexamethasone, Bortezomib, and Daratumumab in Multiple Myeloma

Lilly Wong, Rama Krishna Narla, Jim Leisten et al. · Blood · 2019 · 19 citations

, , +14

Abstract 4694: The humanized anti-CD47 monclonal antibody, CC-90002, has antitumor activity in vitro and in vivo

Rama Krishna Narla, Hardik Modi, Lilly Wong et al. · Cancer Research · 2017 · 14 citations

, , +17

1–4 of 4